or Try an Advanced Search...

    Technical Analysis for RNA - Avidity Biosciences, Inc.

    Grade Last Price % Change Price Change
    B 23.83 -5.02% -1.26
    RNA closed down 5.02 percent on Thursday, April 25, 2024, on approximately normal volume.
    Earnings due: May 7
    *** please verify all earnings dates ***
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Up Flat
    Historical RNA trend table...
    Date Alert Name Type % Chg
    Fell Below 20 DMA Bearish 0.00%
    Bollinger Band Squeeze Range Contraction 0.00%
    Gapped Down Weakness 0.00%
    20 DMA Support Bullish -5.02%
    Bollinger Band Squeeze Range Contraction -5.02%
    Inside Day Range Contraction -5.02%
    Gapped Up Strength -5.02%
    Crossed Above 20 DMA Bullish -5.21%
    New Uptrend Bullish -5.21%
    Bollinger Band Squeeze Range Contraction -5.21%
    Older End-of-Day Signals for RNA ...

       Recent Intraday Alerts

    Alert Time
    10 DMA Support about 9 hours ago
    Down 5% about 13 hours ago
    Fell Below 10 DMA about 13 hours ago
    Down 1 ATR about 13 hours ago
    Gapped Down (Full) about 13 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    RNA Chart by TradingView
    Basic chart:

    Profile

    Avidity Biosciences, Inc. engages in the research and development of biopharmaceutical products. It develops Nano-Medicine Platform that provides nano-medicines for the treatment of cancer and other diseases. The company was founded by Troy E. Wilson, Kent Hawryluk, Mark E. Davis and Francis Patrick McCormick on November 13, 2012 and is headquartered in La Jolla, CA.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Biopharmaceutical Cancer Life Sciences Disease Treatment Of Cancer Pharmaceutical Products Biopharmaceutical Products

    Is RNA a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 18 To The Moon! A Look Inside An ETF Focused On Companies At The Cutting Edge Of Innovation
    Apr 4 Insider Sell: Avidity Biosciences Inc (RNA) President and CEO Sarah Boyce Sells 28,000 Shares
    Apr 2 Avidity Biosciences files to sell 24.26M common shares for holders
    Mar 15 Insider Sell: CFO Michael Maclean Sells 40,000 Shares of Avidity Biosciences Inc (RNA)
    Mar 5 Avidity Biosciences: Targeting A First Ever Approval In DM1 With Improving Data
    Mar 5 A Closer Look at 5 Analyst Recommendations For Avidity Biosciences
    Mar 4 Top 2% Biotech Avidity Collapses Despite 'Positive' Results In Treating Muscular Dystrophy
    Mar 4 Avidity unveils long-term data in myotonic dystrophy trial
    Mar 4 Avidity Biosciences Announces Positive AOC 1001 Long-term Data Showing Reversal of Disease Progression in People Living with Myotonic Dystrophy Type 1 Across Multiple Endpoints; Same Key Endpoints Agreed for Phase 3 HARBOR™ Trial
    Mar 1 Avidity Biosciences Full Year 2023 Earnings: Misses Expectations
    See more RNA news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 27.66
    52 Week Low 4.825
    Average Volume 1,237,084
    200-Day Moving Average 11.61
    50-Day Moving Average 21.69
    20-Day Moving Average 24.74
    10-Day Moving Average 23.95
    Average True Range 1.53
    RSI (14) 50.98
    ADX 22.87
    +DI 21.50
    -DI 24.45
    Chandelier Exit (Long, 3 ATRs) 23.07
    Chandelier Exit (Short, 3 ATRs) 26.15
    Upper Bollinger Bands 27.05
    Lower Bollinger Band 22.43
    Percent B (%b) 0.3
    BandWidth 18.66
    MACD Line 0.54
    MACD Signal Line 0.83
    MACD Histogram -0.2897
    Fundamentals Value
    Market Cap 1.89 Billion
    Num Shares 79.4 Million
    EPS -3.00
    Price-to-Earnings (P/E) Ratio -7.94
    Price-to-Sales 113.02
    Price-to-Book 2.05
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 26.25
    Resistance 3 (R3) 26.35 25.66 25.84
    Resistance 2 (R2) 25.66 25.04 25.60 25.71
    Resistance 1 (R1) 24.74 24.66 24.40 24.64 25.57
    Pivot Point 24.05 24.05 23.87 23.99 24.05
    Support 1 (S1) 23.13 23.43 22.79 23.03 22.09
    Support 2 (S2) 22.44 23.05 22.38 21.95
    Support 3 (S3) 21.52 22.44 21.82
    Support 4 (S4) 21.42